New mutation raises risk for AFib, heart failure for people of color
Study published in JAMA Cardiology
2021-05-06
(Press-News.org) A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
The discovery, made by researchers at the University of Illinois Chicago, could change current guidelines that recommend against genetic testing in people with atrial fibrillations, also known as AFib.
"We found that this new variant confers a significantly increased risk in African Americans, and this mutation has a 50% chance of being passed on to offspring," said Dr. Dawood Darbar, UIC professor of medicine and pharmacology at the College of Medicine. "Since it increases risk for heart failure, it would be wise to test people with atrial fibrillation to see if they carry this dangerous gene."
AFib is the most prevalent heart rhythm disorder worldwide and increases the risk of stroke, heart failure and even dementia.
Previous research from Darbar's lab identified several genes with variations or mutations that increased the risk of early-onset AFib in white people. One of these variants is in a gene called Titan -- the largest gene in the human genome.
Darbar and colleagues sequenced the genes associated with increased risk of early-onset AFib in 227 Black and Latino patients with early-onset AFib who were seen at UI Health, UIC's health care system.
"With early-onset AFib, which we defined in our research as younger than age 65, the likelihood that AFib is genetic, or familial in its cause, is much higher," Darbar said.
They found that 7% of these patients had at least one genetic variation associated with an increased risk of AFib. Among these patients, 50% had a mutation in the Titan gene.
"The Titan mutation is very strongly associated with an increased risk for heart failure as well as AFib, which suggests that African Americans and Hispanic/Latinos with early-onset AFib be screened for this dangerous gene," Darbar said.
Darbar and colleagues also discovered a new genetic variation they think might be associated with an increased risk of early-onset AFib.
"The new gene we discovered was present in six families with two or more individuals with early-onset AFib, making this gene very suspicious," Darbar said. "We will be looking into the significance of this variation in our future studies."
INFORMATION:
Brandon Chalazan, Denise Mol, Faisal Darbar, Aylin Ornelas-Loredo, Bahaa Al-Azzam, Yining Chen, David Tofovic, Arvind Sridhar and Zain Alzahrani of UIC and Patrick Ellinor of Massachusetts General Hospital are co-authors of the paper.
This work was supported in part by grants from the American Heart Association (17MCPRP33420153) and the National Institutes of Health (R01HL138737, T32HL139439).
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-06
According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services -- which are services that help remove barriers to accessing necessary medications -- than comparably sized non-340B hospitals.
The University of Illinois Chicago researchers who conducted the study, which included a survey of available services sent to a nationally representative sample of hospitals across the U.S., suggest that 340B participating hospitals may be better positioned to create and administer programs that support patients who are uninsured ...
2021-05-05
Older people with kidney disease have a higher risk of dementia, and the risk increases with the rate and stage of kidney function decline. That is according to a large observational study by researchers at Karolinska Institutet in Sweden, published in the journal Neurology. The findings stress the significance of screening and monitoring for dementia in persons with kidney disease, the researchers say.
"Our study underscores the importance of low kidney function as a possible under-recognized risk factor for dementia," says co-author Juan Jesus Carrero, professor at the Department ...
2021-05-05
With increased media attention and political campaigns focusing on the gender pay gap, the fact that women -- on average -- are paid less than men, has become an important public discussion. While much of the focus has been on the corporate sector, a new study that looked at executive compensation at nonprofit organizations found that women earn 8.9% less than men with the gap becoming greater when there is room for salary negotiations.
The study co-authored by Curtis Hall, PhD, an associate professor in Drexel University's LeBow College of Business; Andrew R. Finley, assistant professor at the Robert Day School of Economics and Finance at Claremont McKenna College; and LeBow College of Business doctoral student Amanda R. Marino, analyzed data from IRS ...
2021-05-05
A multidisciplinary team of researchers from INRAP, CNRS, the universities of Ottawa, Rennes 2, Toulouse III Paul Sabatier and the Max Planck Institute has recognised the soldiers of the last battles of the siege of Rennes in 1491. These are the only witnesses of the forces involved in the conflict between the armies of Duchess Anne of Brittany and the King of France. This research and its methodology are currently the subject of two articles in the PLOS ONE review.
The excavation of the Jacobins convent in Rennes
From 2011 to 2013, a team from INRAP excavated the convent of the Jacobins, site of the future congress centre in Rennes Métropole, giving rise to numerous scientific ...
2021-05-05
New Haven, Conn. -- A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.
The study, published May 5 in JAMA Network Open, covers 34 novel drugs sponsored by large pharmaceutical companies that the U.S. Food and Drug Administration (FDA) approved between 2012 and 2014. Approvals were made on the basis of a total of 898 trials that were held in the United States and 70 other countries worldwide.
By analyzing the 563 trials for which location data was available, the researchers found that, five years after approval in the United States, only 15% of the drugs ...
2021-05-05
By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine.
Amynah Pradhan, associate professor of psychiatry at the University of Illinois Chicago, is the senior author of the study, whose goal was to identify a new mechanism of chronic migraine, and propose a cellular pathway for migraine therapies. The study, "Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition, is published in eLife.
Pradhan, whose research focus is on the neurobiology of pain and headache, explained that the dynamic process of routing and rerouting connections among nerve ...
2021-05-05
PHILADELPHIA-- It turns out that not all build-ups of tau protein are bad, and a team of researchers from the Perelman School of Medicine at the University of Pennsylvania developed a method to show that. Using mammalian cell models, the researchers combined extremely high-resolution microscopy with machine learning to show that tau actually forms small aggregates when a part of the body's normal physiology. Through this, they could distinguish between the aggregates occurring under healthy conditions from the ones associated with neurological diseases, potentially opening the door to screening for treatments that ...
2021-05-05
Scientists from Russia and Italy studied a new axis of the pathway that prevents the development of liver fibrosis. The role of GILZ protein in curbing the disease progression was shown in a study using mice models and confirmed by clinical data. These findings can be used in the treatment of liver fibrosis in humans. The research was published in the journal Cell Death & Disease.
Fibrosis combines an overgrowth of connective tissue and a decline in the liver function that can be caused by a viral infection, alcohol intoxication, autoimmune diseases or other liver disorders. If left untreated, fibrosis can lead to cirrhosis and even death. ...
2021-05-05
LOS ALAMOS, N.M., May 5, 2021-- A massive collaborative research project covered in the journal Nature this week offers projections to the year 2100 of future sea-level rise from all sources of land ice, offering the most complete projections created to date.
"This work synthesizes improvements over the last decade in climate models, ice sheet and glacier models, and estimates of future greenhouse gas emissions," said Stephen Price, one of the Los Alamos scientists on the project. "More than 85 researchers from various disciplines, including our team at Los Alamos National Laboratory, produced sea-level rise projections based on the most recent ...
2021-05-05
Sea ice cover in the Southern Hemisphere is extremely variable, from summer to winter and from millennium to millennium, according to a University of Maine-led study. Overall, sea ice has been on the rise for about 10,000 years, but with some exceptions to this trend.
Dominic Winski, a research assistant professor at the UMaine Climate Change Institute, spearheaded a project that uncovered new information about millennia of sea ice variability, particularly across seasons, in the Southern Hemisphere by examining the chemistry of a 54,000-year-old South Pole ice core.
The Southern Ocean experiences the largest seasonal ...
LAST 30 PRESS RELEASES:
[Press-News.org] New mutation raises risk for AFib, heart failure for people of color
Study published in JAMA Cardiology
